Fully Automatic Biochemistry Analyzer Market Report 2024

This Fully Automatic Biochemistry Analyzer market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The fully automatic biochemistry analyzer market size has grown strongly in recent years. It will grow from $3.23 billion in 2023 to $3.39 billion in 2024 at a compound annual growth rate (CAGR) of 5%. The growth observed during the historic period can be attributed to several factors such as increasing demand for high-throughput testing, a rising need for accuracy and precision in diagnostics, the expansion of healthcare facilities, a growing prevalence of chronic diseases, enhanced efficiency of automated systems, and the need for cost reduction in diagnostic processes.

The fully automatic biochemistry analyzer market size is expected to see strong growth in the next few years. It will grow to $4.14 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The anticipated growth in the forecast period can be attributed to several factors such as the integration of artificial intelligence and machine learning, a growing emphasis on personalized medicine, expansion in emerging economies, advancements in molecular diagnostics, an increasing focus on preventive healthcare, demand for integrated healthcare solutions, and rising investment in laboratory automation. Major trends during this period include the development of more compact and portable analyzers, enhanced automation capabilities, advancements in real-time data analysis, integration with electronic health records, improvements in user interface and experience, a focus on increasing assay sensitivity, and the growth of cloud-based data management solutions.

The expansion of clinical and research laboratories is anticipated to drive growth in the fully automatic biochemistry analyzer market. Clinical and research laboratories are facilities engaged in diagnostic testing and scientific research on biological samples. This sector's growth is attributed to increased investments in biomedical research, clinical trials, and personalized medicine. Additionally, significant funding from governments, private organizations, and grants supports the development of these facilities. Fully automatic biochemistry analyzers improve the efficiency and accuracy of these labs by automating complex testing processes, managing large sample volumes, ensuring consistent results, and supporting advanced research initiatives. For instance, in February 2023, the World Health Organization reported that the number of clinical trials in South East Asia increased from 10,966 in 2021 to 11,030 in 2022. This growth in clinical and research laboratories is fueling demand for fully automatic biochemistry analyzers.

Leading companies in the fully automatic biochemistry analyzer market are innovating with new products, such as fully automated urine sediment testing analyzers, to enhance diagnostic precision, streamline workflows, and meet diverse laboratory needs. These analyzers automatically classify and measure urine particles, including red and white blood cells, bacteria, and other substances. For example, in September 2022, Sysmex Corporation, a Japan-based provider of laboratory testing reagents and equipment, introduced the UF-1500 fully automated urine particle analyzer. This model, an upgrade from the UF-5000, is more compact, reducing its footprint by approximately 30%. It offers advanced functionality and usability, suitable for small and medium-sized facilities as well as serving as a backup for larger labs. The UF-1500 automates the classification and measurement of urine particles critical for diagnosing renal and urinary tract disorders.

In December 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a China-based medical technology provider, acquired a 75% stake in DiaSys Diagnostic Systems GmbH. This acquisition, the terms of which were undisclosed, aims to strengthen Mindray's global position in the IVD sector by leveraging DiaSys's established supply chains and expertise in clinical chemistry. DiaSys Diagnostic Systems GmbH, based in Germany, is known for its fully automated chemistry analyzers.

Major companies operating in the fully automatic biochemistry analyzer market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Fujifilm Corporation, Becton Dickinson (BD) Company, Agilent Technologies, Mindray Bio-Medical Electronics Co. Ltd., Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics, Horiba Medical Ltd, DiaSorin S.p.A., Randox Laboratories Ltd., Luminex Corporation, Schiller AG, Dirui Industries Co. Ltd., Trivitron Healthcare Ltd, EKF Diagnostics Holdings plc, A. Menarini Diagnostics Srl, Analytical Technologies Limited, Urit Medical Electronic Group, Adaltis Inc.

Europe was the largest region in the fully automatic biochemistry analyzer market in 2023. The regions covered in the fully automatic biochemistry analyzer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fully automatic biochemistry analyzer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A fully automatic biochemistry analyzer is a sophisticated laboratory instrument designed to perform a broad range of biochemical tests with minimal manual intervention. It automates the processes of sample handling, reagent management, and result analysis, ensuring high throughput and consistency. This automation provides rapid and accurate results, minimizing human error and reducing operational costs.

The main types of fully automatic biochemistry analyzers include bench-top and floor-standing models. Bench-top analyzers are compact units designed to be placed on a laboratory counter or bench, making them suitable for smaller laboratories or facilities with limited space. They offer an efficient solution for automated biochemical testing while maintaining high performance. Applications of these analyzers encompass disease diagnosis, drug abuse testing, drug discovery, in vitro diagnostics, and more. End users include pharmaceutical and biotech companies, hospitals and clinics, diagnostic laboratories, and point-of-care centers.

The fully automatic biochemistry analyzer market research report is one of a series of new reports that provides fully automatic biochemistry analyzer market statistics, including fully automatic biochemistry analyzer industry global market size, regional shares, competitors with an fully automatic biochemistry analyzer market share, detailed fully automatic biochemistry analyzer market segments, market trends and opportunities, and any further data you may need to thrive in the fully automatic biochemistry analyzer industry. This fully automatic biochemistry analyzer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A fully automatic biochemistry analyzer market consists of sales of products such as advanced analyzers, reagent kits, control and calibration solutions, software for data management, and related consumables to enhance laboratory efficiency, ensure accurate and high-throughput testing, and support comprehensive diagnostic workflows. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.